These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1333186)

  • 1. Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus.
    Kato N; Ootsuyama Y; Ohkoshi S; Nakazawa T; Sekiya H; Hijikata M; Shimotohno K
    Biochem Biophys Res Commun; 1992 Nov; 189(1):119-27. PubMed ID: 1333186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sequence diversity and variability in the putative envelope proteins including hypervariable regions of hepatitis C virus].
    Nakazawa T; Hijikata M; Kato N; Shimotohno K
    Nihon Rinsho; 1993 Feb; 51(2):318-22. PubMed ID: 8385235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier.
    Nakazawa T; Kato N; Ootsuyama Y; Sekiya H; Fujioka T; Shibuya A; Shimotohno K
    Int J Cancer; 1994 Jan; 56(2):204-7. PubMed ID: 8314302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection.
    Kato N; Ootsuyama Y; Sekiya H; Ohkoshi S; Nakazawa T; Hijikata M; Shimotohno K
    J Virol; 1994 Aug; 68(8):4776-84. PubMed ID: 7518526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus.
    Kato N; Sekiya H; Ootsuyama Y; Nakazawa T; Hijikata M; Ohkoshi S; Shimotohno K
    J Virol; 1993 Jul; 67(7):3923-30. PubMed ID: 7685404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses.
    Kato N; Ootsuyama Y; Tanaka T; Nakagawa M; Nakazawa T; Muraiso K; Ohkoshi S; Hijikata M; Shimotohno K
    Virus Res; 1992 Feb; 22(2):107-23. PubMed ID: 1314471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2 quasispecies specificity of hepatitis C virus association with allografts immediately after liver transplantation.
    Hughes MG; Rudy CK; Chong TW; Smith RL; Evans HL; Iezzoni JC; Sawyer RG; Pruett TL
    Liver Transpl; 2004 Feb; 10(2):208-16. PubMed ID: 14762858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.
    Weiner AJ; Geysen HM; Christopherson C; Hall JE; Mason TJ; Saracco G; Bonino F; Crawford K; Marion CD; Crawford KA
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3468-72. PubMed ID: 1314389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus population dynamics in human lymphocytes and hepatocytes infected in vitro.
    Kato N; Ikeda M; Sugiyama K; Mizutani T; Tanaka T; Shimotohno K
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1859-69. PubMed ID: 9714233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1.
    Sekiya H; Kato N; Ootsuyama Y; Nakazawa T; Yamauchi K; Shimotohno K
    Int J Cancer; 1994 Jun; 57(5):664-70. PubMed ID: 7515022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary study of hepatitis C virus envelope genes during primary infection.
    Chen S; Wang YM
    Chin Med J (Engl); 2007 Dec; 120(24):2174-80. PubMed ID: 18167197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iatrogenic transmission of hepatitis C virus (HCV) by an anesthesiologist: comparative molecular analysis of the HCV-E1 and HCV-E2 hypervariable regions.
    Shemer-Avni Y; Cohen M; Keren-Naus A; Sikuler E; Hanuka N; Yaari A; Hayam E; Bachmatov L; Zemel R; Tur-Kaspa R
    Clin Infect Dis; 2007 Aug; 45(4):e32-8. PubMed ID: 17638183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
    Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
    Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype distribution and comparison of the putative envelope region of hepatitis C virus from Korean patients.
    Kim CJ; Shin KS; Kim WY; Lim DS; Yoon SK; Park YM; Kim BS; Jang SK; Cho MJ
    J Med Virol; 1995 Aug; 46(4):380-6. PubMed ID: 7595417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients.
    Scarselli E; Cerino A; Esposito G; Silini E; Mondelli MU; Traboni C
    J Virol; 1995 Jul; 69(7):4407-12. PubMed ID: 7539508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of hypervariable regions (HVR1 and HVR2) in positive- and negative-stranded hepatitis C virus RNA in cancerous and non-cancerous liver tissue, peripheral blood mononuclear cells and serum from a patient with hepatocellular carcinoma.
    Saito S; Kato N; Hijikata M; Gunji T; Itabashi M; Kondo M; Tanaka K; Shimotohno K
    Int J Cancer; 1996 Jul; 67(2):199-203. PubMed ID: 8760588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region.
    Driesel G; Wirth D; Stark K; Baumgarten R; Sucker U; Schreier E
    Arch Virol; 1994; 139(3-4):379-88. PubMed ID: 7832643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequences in the hypervariable region 1 of hepatitis C virus show only minimal variability in the presence of antibodies against hypervariable region 1 during acute infection in chimpanzees.
    Zhou YH; Sugitani M; Esumi M
    Arch Virol; 2002 Oct; 147(10):1955-62. PubMed ID: 12376756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A correlation between the heterogeneity of hypervariable region 1 of E2 glycoprotein of Hepatitis C virus (HCV) and HCV antibody profile: a case study.
    Kmieciak D; Biernacka-Lukanty J; Migdalski P; Turek-Plewa J; Wierzbicki A; Juszczyk J; Trzeciak WH
    Acta Virol; 2005; 49(2):97-103. PubMed ID: 16047736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.